Skip to content
Back to Guavy Wire
Forex

Dimensional Fund Advisors Cuts Stake in Rhythm Pharmaceuticals

Instruments
CHF
Share

Dimensional Fund Advisors LP recently reduced its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) by selling 12,867 shares during the first quarter. This represents a 40.2% decrease in their holdings.

The fund now owns 19,151 shares of the company's stock, valued at $1,666,000. Other hedge funds also made significant changes to their positions in Rhythm Pharmaceuticals during the same period.

AlphaCentric Advisors LLC increased its stake by 84.0% and now owns 9,297 shares worth $809,000. Swiss National Bank boosted its holdings by 0.8%, purchasing an additional 900 shares for a total of 112,200 shares valued at $9,758,000.

More on Forex

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc